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16Fibrodysplastic implications for transvenous
embolization of a high-ﬂow pelvic arteriovenous
malformation in Osler-Weber-Rendu syndrome
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Osler-Weber-Rendu syndrome is a rare genetic disorder that commonly features high-ﬂow arteriovenous malformations
(AVM) within the pulmonary, intracranial, and visceral circulation. We present a patient with a unique case of Osler-
Weber-Rendu syndrome featuring a high-ﬂow pelvic AVM in addition to ﬁbromuscular dysplasia affecting multiple
vascular beds. This required a unique modiﬁcation of our embolic therapeutic approach for adequate treatment of the
AVM. (J Vasc Surg Cases 2015;1:16-9.)Osler-Weber-Rendu (OWR) syndrome is a rare genetic
disorder that commonly features high-ﬂow arteriovenous
malformations (AVM) within the pulmonary, intracranial,
and visceral circulation. We present a patient with a unique
case of OWR syndrome featuring a high-ﬂow pelvic AVM
in addition to ﬁbromuscular dysplasia (FMD) affecting
multiple vascular beds. Consent to publish this case report
was obtained from patient.
CASE REPORT
A 59-year-old woman with a history of OWR syndrome was
evaluated in consultation for a symptomatic left pelvic AVM
discovered on a computed tomography (CT) scan. Symptoms
included a dull, throbbing ache, waxing and waning in severity,
with exacerbation of symptoms after activity. She also reported a
personal and ﬁrst-degree relative history of chronic, persistent
epistaxis. Her physical examination was remarkable for multiple,
widespread erythematous macules (telangiectasias) throughout
the volar aspect of the acral digits, tongue, and buccal mucosa
(Fig 1, A and B). Left lower quadrant tenderness to deep palpation
and a faint local bruit was appreciated.
The CT scan conﬁrmed the presence of large-caliber, tortuous
arterial feeders supplying the nidus of a high-ﬂow left pelvic AVM
with prompt shunting into an aneurysmal draining vein, which
eventually emptied into the left gonadal venous system (Fig 1,
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were unremarkable aside from mild microcytic anemia.
The patient was offered a diagnostic angiography with the op-
tion for transcatheter embolization of this symptomatic, high-ﬂow
AVM.
Technical details. The procedure was performed in a hybrid
operating suite, with the patient under general anesthesia. No sys-
temic anticoagulation was given; however, generous and frequent
heparinized saline irrigation of sheaths and catheters was per-
formed throughout the case. Flush aortography conﬁrmed the
presence of a high-ﬂow AVM supplied by an enlarged, redun-
dant, and extremely tortuous left gonadal artery, with prompt
shunting into aneurysmal draining veins, which eventually emptied
into the left gonadal venous system. No signiﬁcant left renal vein
hemodynamic abnormalities were noted. Selective catheterization
of the left hypogastric artery revealed no association with the
AVM. Also noted were diffuse, medial ﬁbrodysplastic lesions with a
characteristic chain of beads appearance involving the bilateral
external iliac arteries and the left renal artery (Fig 2, A and B).
Selective catheterization of the ostium of the left gonadal ar-
tery also revealed proximal ﬁbrodysplastic lesions. This lesion,
along with the extreme tortuosity of the feeding artery, precluded
transarterial microcatheter delivery of our embolic agent into the
AVM nidus (Fig 2, C and D).
At this point, venous access was obtained, and the left renal
vein was catheterized. A selective venogram demonstrated two ma-
jor venous channels draining the AVM nidus. The smaller of the
two venous conduits was accessed, followed by insertion of a 6F
Raabe sheath (Cook Medical, Bloomington, Ind; Fig 3, A). A
venogram was performed, and under roadmap guidance, retro-
grade superselective microcatheterization of the AVM nidus was
performed with a 2.4F tipped microcatheter on a 0.014-inch plat-
form (Fig 3, B). Two giant detachable framing coils, 24 mm 
55 cm and 32 mm  60 cm (Ruby; Penumbra, Alameda, Calif),
were placed into the nidus extending into the aneurysmal draining
veins. This provided a scaffold for further embolization using
Onyx-18 and Onyx-34 (Covidien, Plymouth, Minn; Fig 3, C).
Completion venograms and angiograms revealed complete
obliteration of the nidus, with cessation of arteriovenous shunting
and preservation of ovarian arterial inﬂow and venous drainage
(Fig 3, C andD). There was no evidence of nontarget embolization.
Fig 1. Characteristic (A) volar digital and (B) tongue telangiectasias as well as (C) a high-ﬂow arteriovenous mal-
formation (AVM) within the pelvic circulation strongly suggestive of Osler-Weber-Rendu (OWR) syndrome.
Fig 2. Diffuse ﬁbrodysplastic lesions affecting the (A) external iliac, (B) renal, and (C) proximal left gonadal arteries.
C, Along with the extreme tortuosity of the distal left gonadal artery, precluded superselective microcatheterization of
the (D) nidus of the arteriovenous malformation (AVM) from transarterial route.
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well, without any complications, and was discharged home in sta-
ble condition, without symptoms, on postoperative day 1. She was
seen in follow-up at 1 month, with no further abdominal or pelvic
discomfort. She will be monitored with repeat CT angiography at
6 months and then annually thereafter.
DISCUSSION
OWR syndrome, also known as hereditary hemorrhagic
telangiectasia (HHT), is a genetic disorder affecting one in
5000 to 8000 individuals.1,2 High-ﬂow AVMs are a hall-
mark feature of this disorder owing to ectatic changes
involving the precapillary arterioles that can cause secondaryAV shunting.3 These AVMs are formed during development
but generally do not become symptomatic until adolescence
or later.4 The architecture of the AVMs is fragile, and they
are thus easily perturbed, leading to frequent bruising and
bleeding.1,5 The most common symptom of OWR syn-
drome, therefore, is frequent and persistent epistaxis,
mucosal, palmar, and plantar telangiectasias, and visceral,
cranial, or pulmonary AVMs.1 The HHT Foundation Inter-
national Inc has set the clinical diagnostic criteria for a “def-
inite” diagnosis as presence of at least three symptoms from
(1) persistent epistaxis, (2) telangiectasias, (3) AVMs, and
(4) history of a ﬁrst-degree relative with HHT.6 The pres-
ence of at least two symptoms and fewer than two symptoms
Fig 3. A, Transvenous catheterization of draining gonadal vein with sheath insertion. B, Superselective microcatheter
access into arteriovenous malformation (AVM) nidus with deposition of detachable giant framing coils and Onyx
(Covidien, Plymouth, Minn) cast. C and D, Completion angiography and venography demonstrates devascularization
of the AVM nidus with no further arteriovenous shunting and preservation of gonadal artery ﬂow and venous drainage.
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ses, respectively.6
The gene mutations seen in OWR syndrome are part of
the transforming growth factor-b (TGF-b) signaling
cascade.7 Endoglin (ENG) and activin-receptor like kinase
1 (ALK1) are two genes affected in OWR syndrome and
are thought to be responsible for downstream induction of
endothelial proliferation and migration in angiogenesis.1,7
TGF-b involvement is of particular interest in this
patient due to the concurrent observation of FMD
affecting multiple vascular beds. Although the mechanisms
of involvement have not been completely delineated,
Ganesh et al8 found evidence of signiﬁcantly increased
levels of TGF-b in patients with FMD. No direct correla-
tion has been shown to OWR syndrome, but FMD has
been implicated in connections to a number of connective
tissue and cell growth diseases, including neuroﬁbroma-
tosis, Alport syndrome, Ehlers-Danlos syndrome, Marfan
syndrome, and Takayasu arteritis.9 Whether alterations in
TGF-b expression in OWR syndrome can cause secondary
ﬁbrodysplastic lesions remains an interesting question to be
answered by larger retrospective observational studies and
warrants closer biomolecular scrutiny.
In this patient, superselective arterial access into the
AVM nidus proved extremely difﬁcult owing to extreme
tortuosity and proximal ﬁbrodysplastic changes of the
left gonadal artery. However, because the angioarchitec-
ture of the AVM, including its precise pattern of venous
drainage, had been ascertained on delayed-phase diag-
nostic angiography, a transvenous route to the AVM
nidus via a coaxial microcatheter-based system was
proposed and performed successfully. Retrograde ap-
proaches to high-ﬂow AVM embolization have beendescribed mostly within the neurointerventional litera-
ture.10-13
Almost all reported cases involving the use of a poly-
merizing embolic agent describe use of adjunctive tech-
niques, such as balloon occlusion control of the inﬂow
artery or outﬂow vein, or both, to minimize risk of
nontarget embolization into the catheterized draining
vein.14-17 Conway et al18 recently reported a series of ﬁve
patients with high-ﬂow pelvic AVMs in whom transvenous
coil or plug embolization was used as an adjunctive mea-
sure to transarterial or direct stick glue embolization, or
both, of the AVM nidus.
Our approach was unique in that the entire treatment
was performed purely from a transvenous route. Further-
more, careful evaluation of the venous drainage pattern
identiﬁed two major draining veins emptying into the left
renal venous circulation. Selection of the smaller of the
two draining veins and subsequent sheath insertion sufﬁ-
ciently halted ﬂow through that conduit and eliminated
the need for adjunctive techniques to control ﬂow. There-
fore, once microcatheterization of the nidus was achieved,
coil and Onyx embolization was performed with excellent
deposition and no evidence of nontarget embolization. We
initially created a scaffold using two giant framing coils
and higher-viscosity Onyx-34. This provided a foundation
for further embolization with lower-viscosity Onyx-18 for
further devascularization and elimination of the AVM nidus
as well as the aneurysmal portion of the draining veins.
CONCLUSIONS
This represents yet another effective approach to the
treatment of complex AVMs in the setting of compromised
inﬂow access. An alternative option would have been direct
JOURNAL OF VASCULAR SURGERY CASES
Volume 1, Number 1 Nassiri et al 19stick embolization of the AVM nidus under roadmap guid-
ance after initial diagnostic angiography. However, given
the particular location and angioarchitecture of this speciﬁc
AVM, this approach would have proven difﬁcult with po-
tential for adjacent organ injury.
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